| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1378/CHEST.95.2_SUPPLEMENT.118S |
| P698 | PubMed publication ID | 2644094 |
| P2093 | author name string | J Alexander | |
| M Dunn | |||
| R de Silva | |||
| F Hildner | |||
| P433 | issue | 2 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atrial fibrillation | Q815819 |
| P304 | page(s) | 118S-127S | |
| P577 | publication date | 1989-02-01 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Antithrombotic therapy in atrial fibrillation | |
| P478 | volume | 95 |
| Q36751064 | A review of direct current cardioversions for atrial arrhythmia |
| Q33606832 | Antiplatelet therapy--Part I |
| Q52368131 | Artificial neural networks for the diagnosis of atrial fibrillation. |
| Q33989688 | Assessment of low-molecular-weight heparin trials in cardiology |
| Q41023271 | Atrial anatomy and function postcardioversion: insights from transthoracic and transesophageal echocardiography |
| Q38640147 | Cardioversion of atrial fibrillation |
| Q74811003 | Clinical pharmacology of antiarrhythmic drugs |
| Q33617451 | Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation |
| Q40482653 | Contemporary management of atrial fibrillation |
| Q41023258 | Current recommendations for the anticoagulation of patients with atrial fibrillation. |
| Q33174776 | Familial idiopathic atrial fibrillation with bradyarrhythmia |
| Q51021305 | Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. |
| Q77643948 | Hypofibrinolysis in atrial fibrillation |
| Q33617257 | Long-term anticoagulation. Indications and management |
| Q28166939 | Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study |
| Q28316082 | Risk-benefit assessment of anticoagulant therapy |
| Q36951913 | Stroke prevention in nonvalvular atrial fibrillation: A review of prospective randomized trials |
| Q71691181 | The management of atrial fibrillation |
| Q40395459 | The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. |
| Q68182213 | Thyroid disease in the elderly |
| Q36811509 | Treatment of atrial fibrillation in a district general hospital |
| Q41334466 | Value of transoesophageal echocardiography before DC cardioversion in patients with atrial fibrillation: assessment of embolic risk |
| Q44675768 | Warfarin and the International Normalized Ratio: Reducing Interlaboratory Effects |
| Q50532806 | [Improvement in fibrinolytic function following anticoagulant treatment in chronic rheumatic atrial fibrillation] |
| Q80253690 | [TEE-guided cardioversion in patients with atrial fibrillation without previous anticoagulation] |
Search more.